Showing results (111-120 of 315) with videos related to
Sort By:
Pageof 32
Urology|May 11, 2005
Model to predict prostate biopsy outcome in large screening population with independent validation in referral settingChristopher R Porter, Eduard J Gamito, E David Crawford, et al.Clinical Prostate Cancer|March 30, 2004
Ten-year survival in patients with metastatic prostate cancerCatherine M Tangen, James R Faulkner, E David Crawford, et al.Cancer|September 7, 2002
Phase I trial of interferon alpha2b and liposome-encapsulated all-trans retinoic acid in the treatment of patients with advanced renal cell carcinomaJonathan S Goldberg, Manuel Vargas, Alyssa S Rosmarin, et al.Current Urology Reports|May 5, 2005
Local and systemic therapy for patients with metastatic prostate cancer: should the primary tumor be treated?Edith D Canby-Hagino, Gregory P Swanson, E David Crawford, et al.Reviews in Urology|September 21, 2006
Chemoprevention strategies in the prostate: an overviewGary J Kelloff, Howard R Higley, Michael K Brawer, et al.Urology|November 14, 2002
Predicting the outcome of prostate biopsy in a racially diverse population: a prospective studyChristopher R Porter, Colin O'Donnell, E David Crawford, et al.European Urology|January 21, 2014
Disease control outcomes from analysis of pooled individual patient data from five comparative randomised clinical trials of degarelix versus luteinising hormone-releasing hormone agonistsLaurence Klotz, Kurt Miller, E David Crawford, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 16, 2007
Variant in sex hormone-binding globulin gene and the risk of prostate cancerSonja I Berndt, Nilanjan Chatterjee, Wen-Yi Huang, et al.Abdominal Imaging|July 21, 2014
Multi-parametric MRI findings of transitional zone prostate cancers: correlation with 3-dimensional transperineal mapping biopsySajal S Pokharel, Nayana U Patel, Kavita Garg, et al.Urology Practice|August 4, 2023
Moving Forward the State of the Art in Prostate Cancer Treatment: Targeted Focal TherapyE David Crawford, Kyle O Rove, Nelson N Stone, et al.Pageof 32